Senate Confirms McClellan As FDA Commissioner, Ending 21-Month Wait
This article was originally published in The Gray Sheet
Executive Summary
The Senate ended FDA's longest interim period without a commissioner (21 months) by confirming Mark McClellan, MD/PhD, to the post Oct. 17
You may also be interested in...
Com. McClellan starts after election day
Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. McClellan, currently a White House health policy advisor, was cleared by the Senate Oct. 17 (1"The Gray Sheet" Oct. 21, 2002, p. 8)...
Com. McClellan starts after election day
Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. McClellan, currently a White House health policy advisor, was cleared by the Senate Oct. 17 (1"The Gray Sheet" Oct. 21, 2002, p. 8)...
McClellan Outlines Vision For Device User Fees, Third-Party Inspections
Incoming FDA commissioner Mark McClellan, MD/PhD, is pledging to hold the agency to premarket review performance goals mandated under the "Medical Device User Fee and Modernization Act" if the bill becomes law